Bnp Paribas Arbitrage, Snc »

Rapt Therapeutics shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2025-12-31 $17k 498 33.87
2025-09-30 $2.0k 79 25.78
2025-06-30 $1.1k 135 8.00

More positions owned by Bnp Paribas Arbitrage, Snc

NVIDIA Corp Equity (NVDA)
Microsoft Corp Equity (MSFT)
Apple Equity (AAPL)
Amazon.com Equity (AMZN)
Meta Platforms Equity (META)
Tesla Equity (TSLA)
Alphabet Equity (GOOGL)
JPMorgan Chase & Co Equity (JPM)
Broadcom Equity (AVGO)
State Street SPDR S&P Biotech ETF Fund (XBI)
Alphabet Equity (GOOG)
State Street SPDR S&P 500 ETF Trust Fund (SPY)
Cisco Systems Equity (CSCO)
Micron Technology Equity (MU)
Advanced Micro Devices Equity (AMD)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Rapt Therapeutics

TCG Crossover Management
Fcpm Iii Services B.v.
OrbiMed Advisors
Rtw Investments
Foresite Capital Management VI
Siren
Vanguard Group
Frazier Life Sciences Management
Ikarian Capital
Braidwell
Soleus Capital Management
Nantahala Capital Management
Caligan Partners
State Street Corporation
Dr. Jeffrey R. Jay, M.D.

View all funds holding Rapt Therapeutics